Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Abgenix Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Abgenix Inc since year 2005.
Table 2 shows the detailed insider transactions of Abgenix Inc since 2005.
The reporting company's ticker symbol is ABGX. The reporting company's CIK number is 1052837.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $5,257,369.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2006-03-30||Schwab Gisela Md (Chief Medical Officer)||Option Ex||200,000||9.75||1,950,000|
|2006-03-24||Wolff Henry Ward (CFO & SVP, Finance)||Option Ex||22,500||9.94||223,762|
|2006-03-24||Schwab Gisela Md (Chief Medical Officer)||Option Ex||51,812||9.75||505,167|
|2006-03-20||Kucherlapati Raju S (Director)||Option Ex||217,600||6.44||1,400,908|
|2006-03-07||Logan Mark B (Director)||Option Ex||162,800||7.23||1,177,532|
Insider trading activities including stock purchases, stock sales, and option exercises of ABGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Abgenix Inc (symbol ABGX, CIK number 1052837) see the Securities and Exchange Commission (SEC) website.